Subscribe
As the risk-free rate shifts, the uses – and limits – of the Sharpe ratio come into relief
Should investors include CEO fecundity in their due diligence?
It’s a tough call, but it looks like investors have underestimated Centrica
Despite underperforming its benchmark, our 2021 Safe Yield cohort reveals why it has been a long-term winner
Is wide analyst disagreement a reliably bearish signal for equities?
Reversal or cuts to planned duty raise may boost shareholder returns – but there are trade-offs
The past year has been a terrible one for small-cap investing, as our Jim Slater-inspired screen attests
This year, going short has been the only reliable strategy in our ideas section
Our long-running quarterly rotation portfolio is in new hands
Retail savers’ desire for yield or prize money suggests the government should stay focused on wholesale markets for green finance